The optimal neoadjuvant chemotherapy regime for muscle-invasive bladder cancer: still an open question?

Andreas Carus^*, Karin Holmsten, Helle Pappot, Anders Ullén

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate › Research › peer-review

Access to Document

@article{106cc72c66a34c828578d8a132f7b81d,

title = "The optimal neoadjuvant chemotherapy regime for muscle-invasive bladder cancer: still an open question?",

author = "Andreas Carus and Karin Holmsten and Helle Pappot and Anders Ull{\'e}n",

year = "2022",

month = dec,

doi = "10.1080/0284186X.2022.2153620",

language = "English",

volume = "61",

pages = "1515--1516",

journal = "Acta Oncologica",

issn = "0284-186X",

publisher = "Taylor & Francis",

number = "12",

}

TY - JOUR

T1 - The optimal neoadjuvant chemotherapy regime for muscle-invasive bladder cancer

T2 - still an open question?

AU - Carus, Andreas

AU - Holmsten, Karin

AU - Pappot, Helle

AU - Ullén, Anders

PY - 2022/12

Y1 - 2022/12

UR - http://www.scopus.com/inward/record.url?scp=85144208551&partnerID=8YFLogxK

U2 - 10.1080/0284186X.2022.2153620

DO - 10.1080/0284186X.2022.2153620

M3 - Comment/debate

C2 - 36484326

VL - 61

SP - 1515

EP - 1516

JO - Acta Oncologica

JF - Acta Oncologica

SN - 0284-186X

IS - 12

ER -